Stock Trading Plan for Monday Mar 13, 2017 in Compound Trading Chat room. $HTBX $MBLY $CERU $VCEL $SDRL $SRRA $MYSZ $MTL $IT – $SPXL, $BLKG, $ONTX, $DUST, $ASM, $SSH, $LGCY, $TRCH, $ESEA, $DRYS, $MGTI – Gold $GLD, Gold Miners $GDX, Silver… (1) Pre-Market Gainers Watch-List: $PTI, $RPRX, $GLYC $SDRL $TNXP $OMER $NVFY $RIOT $XNET $SSC $DPW $NETE $OSTK $SYRS $TEUM $MBOT $MARK $GROW $SRAX Compound Trading Chat Room Stock Trading Plan and Watch list for Friday July 7, 2017; $DGLY, $GBLS, $Usoil, $UWT, $SPY, $VIX, $DXY, $GOLD – $XIV, $WMT, $NFLX, $UUP, $SSH, $LGCY, $TRCH, $ESEA, $LIGA – Gold $GLD, Gold Miners $GDX, Silver $SLV… Exploring Proteostasis Therapeutics (Nasdaq:PTI) stock? View PTI's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Analyzing vTv Therapeutics (Nasdaq:VTVT) stock? View VTVT's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat.
12/27/2019 · Syros Pharmaceuticals (SYRS), a leader in the development of medicines that control the expression of genes, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Tuesday, November 12, 2019 to report its third quarter 2019 financial results and provide a corporate update.
12/19/2019 · Neovasc Inc. Common Shares (NVCN) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.
Free custom interactive stock charts, analyze all the data with a huge range of indicators.. Latest real-time Bats price quote, charts, technicals and opinions. Real-time trade and investing ideas on Syros Pharmaceuticals SYRS from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Stock quote and company snapshot for SYROS PHARMACEUTICALS INC (SYRS), including profile, stock chart, recent news and events, analyst opinions, and research reports. 12/6/2019 · SYRS closed down 0.86 percent on Friday, December 6, 2019, on 62 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.